- Report
- August 2022
- 140 Pages
Global
From €4078EUR$4,250USD£3,526GBP
- Report
- July 2018
- 13 Pages
Global
From €9595EUR$10,000USD£8,297GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €21109EUR$22,000USD£18,253GBP
Aggrenox is a cardiovascular drug used to reduce the risk of stroke in patients who have had a transient ischemic attack (TIA) or ischemic stroke. It is a combination of two drugs, aspirin and extended-release dipyridamole, and is used to reduce the risk of recurrent stroke. Aggrenox is a prescription medication and is available in capsule form. It is typically taken twice daily with food.
Aggrenox is a popular drug in the cardiovascular market, as it is effective in reducing the risk of stroke. It is also well-tolerated by most patients, with few side effects. Aggrenox is often prescribed in combination with other medications, such as anticoagulants, to further reduce the risk of stroke.
Companies in the Aggrenox market include Boehringer Ingelheim, Pfizer, and Mylan. Show Less Read more